1.Cutaneous Rosai-Dorfman disease in a 40-year-old female: A case report
Joland A. San Juan ; Juan Antonio D. Cervantes ; Johannes F. Dayrit ; Ricky H. Hipolito ; Ma. Teresita G. Gabriel
Journal of the Philippine Dermatological Society 2021;30(1):53-56
Introduction:
Rosai-Dorfman disease is a rare disease that manifests with painless cervical lymphadenopathy, fever, anemia,
an elevated erythrocyte sedimentation rate (ESR), and hypergammaglobulinemia. Extranodal lesions occur in 1/3 of patients, and
the skin is involved in more than 10% of cases. Purely cutaneous disease is uncommon and only about more than 100 cases have
been reported. Cutaneous Rosai-Dorfman Disease (CRDD) appears to be a distinct entity with different age and race predilection
from cases with lymph node involvement.
Case report:
This is a case of a 40-year-old Filipino female who presented with multiple erythematous papules and plaques with
pustules on the cheeks. Skin punch biopsy showed a dense dermal infiltrate of polygonal histiocytes with abundant cytoplasm
and vesicular nuclei. Emperipolesis was also present. The histiocytes were highlighted by the immunohistochemical stains S-100
and CD68 and was CD1a negative. Complete blood count and ESR were normal. Cervical lymphadenopathy was absent. Findings
were consistent with Cutaneous Rosai-Dorfman disease. The patient was started on methotrexate at 15mg/week with folic acid
supplementation. Mild soap, benzoyl peroxide 5% gel and tretinoin 0.05% cream once daily were maintained during the treatment
course. There was significant decrease in erythema and size of existing lesions after 2 months. The patient was referred to a
hematologist for monitoring of possible future systemic involvement.
Conclusion
Because of its rarity, clinicopathological correlation is always mandatory to establish a diagnosis of CRDD. Immu-
nohistochemical stains are required to differentiate this entity form other forms of Langerhans cell histiocytosis. Multidisci-
plinary referral is required to rule out concomitant systemic involvement.
Lymphadenopathy
2.A case of angioimmunoblastic lymphadenopathy with dysproteinemia.
Seong Do CHOI ; Mi Ja KIM ; Yong Wha KIM ; Tae Hong JUNG ; Choon Hae CHUNG ; Mi Ja LEE ; Ho Jong JEON
Korean Journal of Hematology 1992;27(2):399-404
No abstract available.
Immunoblastic Lymphadenopathy*
3.A case of angioimmunoblastic lymphadenopathy presenting as polyarthritis.
Gwan Gyu SONG ; Seon Ho HWANG ; Ji Hoon KIM ; In Hong LEE ; Sung Soo JUNG ; Sang Cheol BAE ; Dae Hyun YOO ; Young Hae KO ; In Soon KIM ; Seong Yoon KIM
Korean Journal of Medicine 1993;45(3):383-387
No abstract available.
Arthritis*
;
Immunoblastic Lymphadenopathy*
4.A case of angioimmunoblastic lymphadenopathy with dysproteinemia followed by Graves' disease.
Jee Sook HAHN ; Uk Hee WON ; Yoo Hong MIN ; Sun Ju LEE ; Yun Woong KO ; Jung Soo PARK ; Kwang Kil LEE
Korean Journal of Hematology 1992;27(2):393-398
No abstract available.
Graves Disease*
;
Immunoblastic Lymphadenopathy*
7.Follicular immunoblastic lymphoma: a clinicopathologic and immunohistochemical study of a case.
Xuanqiu HE ; Lei YANG ; Yanqing DING
Journal of Southern Medical University 2013;33(6):794-797
Primary follicular immunoblastic lymphoma (FIBL) is an extremely rare lymphoma. The positive expression of CD10 suggests the lymphoma originating from germinal centers (GC) and CD138-positive expression generally indicates plasmablastic or plasmacytic differentiation. We report such a rare case in a Chinese female patient and analyze the clinicopathologic and immunohistochemical features of this disease. PET-CT examination was performed to detect signs of systemic lymph node metastasis. We also discussed the differential diagnosis of FIBL from follicular lymphoma (FL) and reactive follicular hyperplasia (RFH). As a rare variant of human follicular lymphoma, FIBL is featured by a neoplastic overgrowth of intrafollicular immunoblasts. Compared with FL, FIBL has a greater chance to evolve into diffuse large B-cell lymphoma with therefore a poorer prognosis.
Adult
;
Female
;
Humans
;
Immunoblastic Lymphadenopathy
;
pathology
;
Lymphoma, Follicular
;
pathology
8.Multi-class discrimination of lymphadenopathy by using dual-modal ultrasound radiomics with elastography and B-mode ultrasound.
Jie SHI ; Jianwei JIANG ; Wanying CHANG ; Man CHEN ; Qi ZHANG
Journal of Biomedical Engineering 2019;36(6):957-963
The purpose of our study is to evaluate the diagnostic performance of radiomics in multi-class discrimination of lymphadenopathy based on elastography and B-mode dual-modal ultrasound images. We retrospectively analyzed a total of 251 lymph nodes (89 benign lymph nodes, 70 lymphoma and 92 metastatic lymph nodes) from 248 patients, which were examined by both elastography and B-mode sonography. Firstly, radiomic features were extracted from multimodal ultrasound images, including shape features, intensity statistics features and gray-level co-occurrence matrix texture features. Secondly, three feature selection methods based on information theory were used on the radiomic features to select different subsets of radiomic features, consisting of conditional infomax feature extraction, conditional mutual information maximization, and double input symmetric relevance. Thirdly, the support vector machine classifier was performed for diagnosis of lymphadenopathy on each radiomic subsets. Finally, we fused the results from different modalities and different radiomic feature subsets with Adaboost to improve the performance of lymph node classification. The results showed that the accuracy and overall 1 score with five-fold cross-validation were 76.09%±1.41% and 75.88%±4.32%, respectively. Moreover, when considering on benign lymph nodes, lymphoma or metastatic lymph nodes respectively, the area under the receiver operating characteristic curve of multi-class classification were 0.77, 0.93 and 0.84, respectively. This study indicates that radiomic features derived from multimodal ultrasound images are benefit for diagnosis of lymphadenopathy. It is expected to be useful in clinical differentiation of lymph node diseases.
Elasticity Imaging Techniques
;
Humans
;
Lymph Nodes
;
Lymphadenopathy
;
Retrospective Studies
;
Ultrasonography
9.Metastatic axillary lymphadenopathy from a triple-negative occult breast carcinoma in a male patient: A case report.
Lara Veronica Louise G. MONTANO ; Louis Matthew C. MANLONGAT ; Francisco Y. ARCELLANA JR.
Philippine Journal of Surgical Specialties 2025;80(1):24-28
Occult Breast Carcinomas (OBCs) are rare. History and physical examination alone may lead to misdiagnosis hence inappropriate investigative and treatment modalities. Diagnosis is difficult without tissue biopsy and extensive immunohistochemical staining. Presented here is a 74-year-old Filipino male with a 2-month history of axillary mass with erythematous skin, initially assessed as hidradenitis suppurativa failing to resolve with antibiotics. An excision biopsy revealed adenocarcinoma within the lymph nodes. Immunohistochemical stains confirmed a breast primary. Radiologic imaging showed no breast lesions and no distant metastasis. Axillary node dissection done showed metastasis to 5 in 14 nodes harvested, classifying him as OBC Stage IIIA (cT0pN2M0). He completed whole breast radiotherapy and chemotherapy. No tumor recurrence was documented thereafter. Although misdiagnosis is common, OBC is a condition to consider in male patients presenting with axillary lymphadenopathy.
Human ; Male ; Aged: 65-79 Yrs Old ; Lymphadenopathy
10.Two Cases of the Angioimmunoblastic Lymphadenopathy Type of Peripheral T - cell Lymphoma : Different Clinical Courses According to Positivity to Epstein-Barr Virus.
Jae Wang KIM ; Sang Ho NAM ; Kwang Joong KIM ; Chong Min KIM ; Chong Ju LEE
Annals of Dermatology 1998;10(2):116-122
Peripheral T-cel1 lymphoma(PTCL) encompasses histopathologically and clinically various spectra of cutaneous T-cell lymphoma(CTCL). In this report, we describe two cases of PTCL showing diRerent clinical courses according to EBV(Epstein-Barr virus) positivity. The chnical course of case 1 with EBV-associated PTCL was rapidby fatal and refractory to intensive chcmotherapy. However, in case 2, EBV genomes were not found in her lesional tissues and she showed an indolent clinical course withoaat systemic symptoms. Accordingly, serological and immunohistochemical investigations for EBV might be mandatory in cutaneous PTCL to evaluate clinical prognosis.
Genome
;
Herpesvirus 4, Human*
;
Immunoblastic Lymphadenopathy*
;
Lymphoma*
;
Lymphoma, T-Cell, Peripheral
;
Prognosis
;
T-Lymphocytes